The number of people with susceptibility test result for rifampicin in Azerbaijan
Azerbaijan: The number of people with susceptibility test result for rifampicin was 1,409 in 2021. ▼ Falling
Latest (2021)
1,409
Change on year
up 13.2%
World rank
59th
of 155 countries
All-time high
1,983
in 2018
All-time low
1,245
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Azerbaijan, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Azerbaijan stood at 1,409.
That represents a change of up 13.2% on the previous year and down 28.6% over five years.
That places Azerbaijan 59th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Azerbaijan, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 1,973 | — |
| 2018 | 1,983 | +0.5% |
| 2019 | 1,911 | -3.6% |
| 2020 | 1,245 | -34.9% |
| 2021 | 1,409 | +13.2% |
Azerbaijan compared with similar countries
- Azerbaijan's 1,409 is above the median for upper middle income countries, which is 880, 1.6× the median. (46 countries reporting)
- Azerbaijan's 1,409 is above the median for Europe & Central Asia, which is 229.5, 6.1× the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1,956 | 1,911 | 1,983 | 3 |
| 2020s | 1,327 | 1,245 | 1,409 | 2 |
Countries ranked near Azerbaijan
More health data for Azerbaijan
- Un projection of annual infant deaths, annual growth rate -1.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1127 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,241 deaths per 1,000 people (2090)
- Number of infants who die before age 1 264 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.72 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0286 units per person (2025)
- Population ages 00-04, male, annual growth rate -4.06 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Azerbaijan?
- The number of people with susceptibility test result for rifampicin in Azerbaijan was 1,409 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Azerbaijan?
- The highest recorded value was 1,983 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Azerbaijan?
- The lowest recorded value was 1,245 in 2020.
- How does Azerbaijan rank for the number of people with susceptibility test result for rifampicin?
- Azerbaijan ranks 59th out of 155 countries with data for 2021.
- Where does this Azerbaijan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).